Karyopharm Therapeutics (KPTI) EPS (Basic) (2012 - 2025)
Karyopharm Therapeutics (KPTI) reported EPS (Basic) of -$7.0 for Q4 2025, down 87.67% on a YoY basis from -$56.76 in Q4 2024, and down 83.25% quarter-over-quarter from -$3.82 in Q3 2025.
Karyopharm Therapeutics (KPTI) EPS (Basic) (2012 - 2025) Analysis & Trends
Karyopharm Therapeutics has reported EPS (Basic) for 14 years, with the latest figure at -$7.0 in Q4 2025.
- For the quarter ending Q4 2025, EPS (Basic) fell 87.67% year-over-year to -$7.0; the trailing twelve-month figure through Dec 2025 stood at -$17.91 (down 76.11% YoY), and the FY2025 full-year result was -$17.93, down 90.54% from the prior year.
- EPS (Basic) for Q4 2025 stood at -$7.0, down from -$3.82 in the prior quarter.
- The five-year high for EPS (Basic) was $2.26 in Q2 2024, with the low at -$17.9 in Q4 2023.
- Historically, EPS (Basic) has averaged -$2.53 across 5 years, with a median of -$0.7 in 2021.
- Annual changes were most pronounced in 2023 — EPS (Basic) tumbled 4161.9% — and 2024, when it soared 879.31%.
- Karyopharm Therapeutics' EPS (Basic) stood at $0.52 in 2021, then sank by 180.77% to -$0.42 in 2022, then plunged by 4161.9% to -$17.9 in 2023, then soared by 79.16% to -$3.73 in 2024, then plunged by 87.67% to -$7.0 in 2025.
- The last three EPS (Basic) figures came in at -$7.0 (Q4 2025), -$3.82 (Q3 2025), and -$4.32 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 0.00 |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 0.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -0.06 |
| 10 | Karyopharm Therapeutics | 95.31 Mn | 31.56 Mn | 32.74 Mn | -7.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.00 |
| Sep 30, 2025 | -3.82 |
| Jun 30, 2025 | -4.32 |
| Mar 31, 2025 | -2.77 |
| Dec 31, 2024 | -3.73 |
| Sep 30, 2024 | -3.85 |
| Jun 30, 2024 | 2.26 |
| Mar 31, 2024 | -4.85 |
| Dec 31, 2023 | -17.90 |
| Sep 30, 2023 | -0.30 |
| Jun 30, 2023 | -0.29 |
| Mar 31, 2023 | -0.30 |
| Dec 31, 2022 | -0.42 |
| Sep 30, 2022 | -0.45 |
| Jun 30, 2022 | -0.62 |
| Mar 31, 2022 | -0.53 |
| Dec 31, 2021 | 0.52 |
| Sep 30, 2021 | -0.69 |
| Jun 30, 2021 | -0.71 |
| Mar 31, 2021 | -0.77 |